Items Per Page 10 25 50 Year All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 August 6, 2026 Delcath Systems Reports Second Quarter 2026 Results and Business Highlights PDF Version July 28, 2026 Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference PDF Version July 23, 2026 Delcath Systems to Host Second Quarter 2026 Earnings Call PDF Version July 16, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version July 9, 2026 Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer PDF Version May 26, 2026 Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts PDF Version May 15, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version May 12, 2026 Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference PDF Version May 7, 2026 Delcath Systems Reports First Quarter 2026 Results and Business Highlights PDF Version May 7, 2026 Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 PDF Version
August 6, 2026 Delcath Systems Reports Second Quarter 2026 Results and Business Highlights PDF Version
July 28, 2026 Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference PDF Version
July 16, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
July 9, 2026 Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer PDF Version
May 26, 2026 Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts PDF Version
May 15, 2026 Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
May 12, 2026 Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference PDF Version
May 7, 2026 Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 PDF Version
